{
  "id": "51601071298dcd4e51000038",
  "type": "list",
  "question": "Against which organisms has reverse vaccinology been used?",
  "ideal_answer": "Reverse Vaccinology (RV) was first applied to serogroup B Neisseria meningitidis. This work induced further research of other pathogens in the same way: Porphyromonas gingivalis, Streptococcus pneumoniae, Chlamydia pneumoniae, Bacillus anthracis, group B streptococci, Helicobacter pylori and Mycobacterium tuberculosis. Concerning animal-affecting organisms, RV has been applied for vaccine design against Theileria parva, Brachyspira hyodysenteriae,  Echinococcus granulosus, Ehrlichia ruminantium, Leishmania spp, Rhipicephalus microplus and Brucella melitensis.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/23527566",
    "http://www.ncbi.nlm.nih.gov/pubmed/22261504",
    "http://www.ncbi.nlm.nih.gov/pubmed/16107075",
    "http://www.ncbi.nlm.nih.gov/pubmed/23514126",
    "http://www.ncbi.nlm.nih.gov/pubmed/17291333",
    "http://www.ncbi.nlm.nih.gov/pubmed/16848907",
    "http://www.ncbi.nlm.nih.gov/pubmed/22521592",
    "http://www.ncbi.nlm.nih.gov/pubmed/20127115",
    "http://www.ncbi.nlm.nih.gov/pubmed/21993656",
    "http://www.ncbi.nlm.nih.gov/pubmed/20671958",
    "http://www.ncbi.nlm.nih.gov/pubmed/23533646",
    "http://www.ncbi.nlm.nih.gov/pubmed/22434357",
    "http://www.ncbi.nlm.nih.gov/pubmed/12531326",
    "http://www.ncbi.nlm.nih.gov/pubmed/11257410",
    "http://www.ncbi.nlm.nih.gov/pubmed/19179021"
  ],
  "snippets": [
    {
      "text": "The potential of this new approach is illustrated by the use of reverse vaccinology for the development of a vaccine against serogroup B meningococcus",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11257410",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The Neisseria meningitidis serogroup B project, the first example of Reverse Vaccinology",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12531326",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Reverse vaccinology and vaccines for serogroup B Neisseria meningitidis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16107075",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "This process, first applied to serogroup B Neisseria meningitidis, has been termed as reverse vaccinology",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16107075",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "A reverse vaccinology approach to swine dysentery vaccine development",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19179021",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Swine dysentery (SD) is a mucohaemorrhagic colitis of pigs resulting from infection of the large intestine with the anaerobic intestinal spirochaete Brachyspira hyodysenteriae",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19179021",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Reverse vaccinology approach identify an Echinococcus granulosus tegumental membrane protein enolase as vaccine candidate",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20127115",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Reverse vaccinology process identified E. granulosus tegumental membrane protein enolase as vaccine candidate",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20127115",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The application of RV to Neisseria meningitidis serogroup B represents the first success of this novel approach",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21993656",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Identification of Ehrlichia ruminantium proteins that activate cellular immune responses using a reverse vaccinology strategy",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22261504",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Ehrlichia ruminantium is an obligate intracellular bacterial pathogen which causes heartwater, a serious tick-borne disease of ruminants throughout sub-Saharan Africa",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22261504",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "A reverse vaccinology approach for the identification of potential vaccine candidates from Leishmania spp",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22434357",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "A systematic, functional genomics, and reverse vaccinology approach to the identification of vaccine candidates in the cattle tick, Rhipicephalus microplus",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22521592",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "Neisseria meningitidis (serogroup B), Porphyromonas gingivalis, Streptococcus pneumoniae, Chlamydia pneumoniae, Bacillus anthracis, group B streptococci, Helicobacter pylori, Mycobacterium tuberculosis, Theileria parva, Brachyspira hyodysenteriae, Echinococcus granulosus, Ehrlichia ruminantium, Leishmania spp, Rhipicephalus microplus, Brucella melitensis"
}